Ironwood Pharmaceuticals
IRWD
IRWD
152 hedge funds and large institutions have $1.76B invested in Ironwood Pharmaceuticals in 2019 Q2 according to their latest regulatory filings, with 30 funds opening new positions, 26 increasing their positions, 96 reducing their positions, and 32 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
less first-time investments, than exits
New positions opened: | Existing positions closed:
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
16.03% less ownership
Funds ownership: 119.69% → 103.66% (-16%)
25% less funds holding in top 10
Funds holding in top 10: 4 → 3 (-1)
73% less repeat investments, than reductions
Existing positions increased: 26 | Existing positions reduced: 96
Holders
152
Holding in Top 10
3
Calls
$8.76M
Puts
$6.2M
Top Buyers
| 1 | +$18.5M | |
| 2 | +$13.5M | |
| 3 | +$10.1M | |
| 4 |
BCPEMI
Bain Capital Public Equity Management II
Boston,
Massachusetts
|
+$8.82M |
| 5 |
SCM
Sarissa Capital Management
Greenwich,
Connecticut
|
+$7.8M |
Top Sellers
| 1 | -$56.6M | |
| 2 | -$44.4M | |
| 3 | -$39.3M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
-$24.4M |
| 5 |
BlackRock
New York
|
-$17.9M |